ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/17 | 1,185 | 1,243 | 1,185 | 1,236 | +9 | +0.7% | 371,900 |
2020/02/14 | 1,213 | 1,234 | 1,197 | 1,227 | +4 | +0.3% | 261,400 |
2020/02/13 | 1,248 | 1,258 | 1,206 | 1,223 | +30 | +2.5% | 474,600 |
2020/02/12 | 1,188 | 1,204 | 1,182 | 1,193 | -3 | -0.3% | 176,400 |
2020/02/10 | 1,190 | 1,196 | 1,172 | 1,196 | +13 | +1.1% | 144,200 |
2020/02/07 | 1,196 | 1,203 | 1,173 | 1,183 | -16 | -1.3% | 143,200 |
2020/02/06 | 1,200 | 1,210 | 1,187 | 1,199 | +9 | +0.8% | 175,100 |
2020/02/05 | 1,210 | 1,222 | 1,189 | 1,190 | -14 | -1.2% | 156,500 |
2020/02/04 | 1,162 | 1,216 | 1,162 | 1,204 | +34 | +2.9% | 228,700 |
2020/02/03 | 1,143 | 1,185 | 1,140 | 1,170 | -24 | -2% | 340,600 |
2020/01/31 | 1,155 | 1,201 | 1,155 | 1,194 | +35 | +3% | 246,900 |
2020/01/30 | 1,230 | 1,240 | 1,151 | 1,159 | -70 | -5.7% | 552,100 |
2020/01/29 | 1,245 | 1,257 | 1,217 | 1,229 | -23 | -1.8% | 215,900 |
2020/01/28 | 1,203 | 1,260 | 1,200 | 1,252 | +39 | +3.2% | 241,900 |
2020/01/27 | 1,201 | 1,243 | 1,201 | 1,213 | -35 | -2.8% | 288,800 |
2020/01/24 | 1,283 | 1,288 | 1,243 | 1,248 | -40 | -3.1% | 385,400 |
2020/01/23 | 1,304 | 1,310 | 1,285 | 1,288 | -25 | -1.9% | 210,900 |
2020/01/22 | 1,297 | 1,325 | 1,282 | 1,313 | +18 | +1.4% | 225,800 |
2020/01/21 | 1,332 | 1,332 | 1,289 | 1,295 | -26 | -2% | 250,100 |
2020/01/20 | 1,310 | 1,342 | 1,301 | 1,321 | +23 | +1.8% | 394,400 |
2020/01/17 | 1,291 | 1,303 | 1,274 | 1,298 | +3 | +0.2% | 208,500 |
2020/01/16 | 1,301 | 1,309 | 1,286 | 1,295 | -10 | -0.8% | 191,500 |
2020/01/15 | 1,292 | 1,309 | 1,289 | 1,305 | +2 | +0.2% | 148,000 |
2020/01/14 | 1,304 | 1,309 | 1,282 | 1,303 | -1 | -0.1% | 180,500 |
2020/01/10 | 1,289 | 1,306 | 1,285 | 1,304 | +12 | +0.9% | 183,300 |
2020/01/09 | 1,310 | 1,314 | 1,278 | 1,292 | +30 | +2.4% | 316,400 |
2020/01/08 | 1,317 | 1,336 | 1,230 | 1,262 | -75 | -5.6% | 1,109,200 |
2020/01/07 | 1,337 | 1,375 | 1,331 | 1,337 | +22 | +1.7% | 444,200 |
2020/01/06 | 1,298 | 1,345 | 1,293 | 1,315 | -26 | -1.9% | 526,000 |
2019/12/30 | 1,427 | 1,437 | 1,338 | 1,341 | +94 | +7.5% | 2,199,800 |
2019/12/27 | 1,238 | 1,256 | 1,221 | 1,247 | +14 | +1.1% | 235,000 |
2019/12/26 | 1,203 | 1,241 | 1,203 | 1,233 | +30 | +2.5% | 401,800 |
2019/12/25 | 1,216 | 1,227 | 1,198 | 1,203 | -24 | -2% | 252,000 |
2019/12/24 | 1,206 | 1,236 | 1,189 | 1,227 | +35 | +2.9% | 403,900 |
2019/12/23 | 1,230 | 1,234 | 1,178 | 1,192 | -39 | -3.2% | 492,700 |
2019/12/20 | 1,210 | 1,243 | 1,200 | 1,231 | +18 | +1.5% | 294,900 |
2019/12/19 | 1,221 | 1,238 | 1,210 | 1,213 | -11 | -0.9% | 174,500 |
2019/12/18 | 1,242 | 1,243 | 1,213 | 1,224 | -29 | -2.3% | 237,100 |
2019/12/17 | 1,203 | 1,255 | 1,203 | 1,253 | +48 | +4% | 290,500 |
2019/12/16 | 1,203 | 1,226 | 1,203 | 1,205 | -28 | -2.3% | 292,900 |
2019/12/13 | 1,277 | 1,277 | 1,231 | 1,233 | -30 | -2.4% | 312,800 |
2019/12/12 | 1,255 | 1,265 | 1,232 | 1,263 | ±0 | ±0% | 324,800 |
2019/12/11 | 1,286 | 1,299 | 1,256 | 1,263 | -32 | -2.5% | 384,100 |
2019/12/10 | 1,315 | 1,319 | 1,294 | 1,295 | -24 | -1.8% | 335,000 |
2019/12/09 | 1,355 | 1,360 | 1,316 | 1,319 | -31 | -2.3% | 220,600 |
2019/12/06 | 1,334 | 1,350 | 1,317 | 1,350 | +21 | +1.6% | 182,500 |
2019/12/05 | 1,330 | 1,337 | 1,312 | 1,329 | +6 | +0.5% | 252,000 |
2019/12/04 | 1,342 | 1,346 | 1,313 | 1,323 | -28 | -2.1% | 321,200 |
2019/12/03 | 1,346 | 1,369 | 1,336 | 1,351 | -10 | -0.7% | 214,700 |
2019/12/02 | 1,395 | 1,407 | 1,355 | 1,361 | -31 | -2.2% | 333,100 |
1351~
1400
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム